![Page 1: Partnering Opportunities & Translational Funding for Neurofibromatosis Neurofibromatosis (NF): - A rare disease - 1:3,000 - Tumor suppressor genes – NF1,](https://reader035.vdocuments.us/reader035/viewer/2022081504/56649d2d5503460f94a04b51/html5/thumbnails/1.jpg)
Partnering Opportunities & Translational Funding for Neurofibromatosis
Neurofibromatosis (NF):- A rare disease - 1:3,000- Tumor suppressor genes – NF1, NF2- Brain/nerve tumors; benign & malignant- Learning disabilities, bone dysplasia, pain
NF Research Today:- Candidate drug targets - Preclinical models - GEMs- Trial pipeline- 44 site NF Clinic Network- NF BioBank & Patient Registry
Why Should You Look at NF?- Cancer crossover - Ras – broad relevance- Growing commercial interest in rare diseases
1
![Page 2: Partnering Opportunities & Translational Funding for Neurofibromatosis Neurofibromatosis (NF): - A rare disease - 1:3,000 - Tumor suppressor genes – NF1,](https://reader035.vdocuments.us/reader035/viewer/2022081504/56649d2d5503460f94a04b51/html5/thumbnails/2.jpg)
2
CTF NF Translational Pipeline Opportunities
engageindustry
Drug Discovery Initiative Clinical Research Award $15K, $30K vitro/vivo screencandidate NF Rx
$100K – pilot clinical trial or biomarker study
![Page 3: Partnering Opportunities & Translational Funding for Neurofibromatosis Neurofibromatosis (NF): - A rare disease - 1:3,000 - Tumor suppressor genes – NF1,](https://reader035.vdocuments.us/reader035/viewer/2022081504/56649d2d5503460f94a04b51/html5/thumbnails/3.jpg)
3
Opportunities for Collaboration with CTF & NF ResearchFUNDING:Drug Discovery Initiative Awards $15K & $30K
- Deadlines Feb & August - 3 page app - fast turnaroundClinical Research Awards $100K - LOI deadline Spring 2011
INDUSTRY/DRUGS:- Growing NF interest – CTF at BIO, FasterCures, etc.- Industry advisors on RAB – AstraZeneca, Lilly, Plexxikon ...
CELLS, ANIMAL MODELS, TISSUES:- Online DDI Toolbox; NF BioBank- CTF MA funded sites e.g. Harvard, MIT, Whitehead, Children’s,
Tufts
CLINICAL TRIALS: Clinical Trials Consortium, Patient Registry
NETWORKING: 2011 NF Conference, Jackson Hole, WY June 11-14. ____________________________________________________Kim Hunter-Schaedle, Ph.D. CSO, Children’s Tumor Foundation
[email protected] www.ctf.org - http://www.partneringforcures.org/2010_innovators/29_neurofib.html